Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor-Reference-Cited by-同舟云学术

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor

Published:2004-05 Issue:3 Volume:89 Page:553-560
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J Neurochem

Author:

Beyer Andrea,Koch Thomas,Schroder Helmut,Schulz Stefan,Hollt Volker

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2004.02340.x/fullpdf

Reference33 articles.

1. A Single Nucleotide Polymorphic Mutation in the Human μ-Opioid Receptor Severely Impairs Receptor Signaling

2. μ opioid receptor gene variants: lack of association with alcohol dependence

3. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors

4. Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction

5. The role of diacylglycerol and activation of protein kinase C in α1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G protein-coupled receptor (GPCR) pharmacogenomics;Critical Reviews in Clinical Laboratory Sciences;2024-08-09

2. Functional differences in the mu opioid receptor SNP 118A>G are dependent on receptor splice‐variant and agonist‐specific recruitment of β‐arrestin;Clinical and Translational Science;2024-08

3. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population;Journal of Applied Biomedicine;2023-09-22

4. Genetic Factors Associated with Morphine Consumption in Women Undergoing Laparoscopic Cholecystectomy: A Prospective Cohort Study;Journal of Pain Research;2023-07

5. Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder;Environmental Toxicology and Pharmacology;2022-10